P3 Health Partners I Warrant 11/19/2026 has returned -33.3% from $0.01 since 2026, trailing SPY's +6.3% over the same period. The stock hit an all-time high of $0.01 in Mar 2026 and is currently 33.3% below that level. Of 5 tracked news events, 80% produced a positive market-adjusted return.
Expand to read Wikipedia-sourced background on the company. Click any linked term to explore it inline — no page reload.
Common questions answered from real data: performance vs SPY, market cap, profitability, CEO, dividends, and more.
Every dot on the chart is a news event. The return shown is market-adjusted (vs SPY). Green = stock outperformed. Red = underperformed. Dot size = magnitude of reaction.
Want the full written briefing?
The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.
| Date | Return | Category | Source | Headline |
|---|---|---|---|---|
| 2026-03-26 | +3.5% | news | Business Wire | P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results |
| 2026-03-26 | +3.5% | earnings | SEC EDGAR | PIIIW 8-K: 2.02 and (SEC Filing) |
| 2026-04-16 | -1.5% | earnings | Business Wire | P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call |
| 2026-03-25 | +1.2% | M&A | SEC EDGAR | PIIIW 8-K: 1.01 and (SEC Filing) |
| 2026-04-28 | +0.5% | M&A | SEC EDGAR | PIIIW 8-K: 1.01, 3.02and5.03 (SEC Filing) |